共 148 条
[1]
Tang T(2009)Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility Cochrane Database Syst Rev 13 CD003053-59
[2]
Lord JM(2006)The impact of obesity on reproduction in women with polycystic ovary syndrome BJOG 113 1148-701
[3]
Norman RJ(2004)The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study J Clin Endocrinol Metab 89 3696-5
[4]
Yasmin E(2001)Low grade chronic inflammation in women with polycystic ovarian syndrome J Clin Endocrinol Metab 86 2453-6
[5]
Balen AH(2002)Altered vascular function in young women with polycystic ovary syndrome J Clin Endocrinol Metab 87 742-82
[6]
Pasquali R(2005)The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome Endocr Rev 26 251-13
[7]
Gambineri A(2001)Oxidative stress in poycystic ovary syndrome and its contribution to the risk of cardiovascular disease Clin Biochem 34 407-12
[8]
Pagotto U(2003)Polycystic ovary syndrome and cardiovascular disease: a premature association Endocrinol Rev 24 302-8
[9]
Orio F(2000)What is the oxidative stress? Metabolism 49 13-67
[10]
Palomba S(1996)Oxidative stres and diabetic vascular complications Diabetes Care 19 257-8